[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J, et al
A one-month supply of compounded semaglutide (mixed with B-12 and glycine), delivered each month with automatic refills for ongoing support
Those are risk markers, not outcomes, and the distinction matters for reasons the next section addresses
This study was thorough and clinically run, but after measuring six major cognitive performance aspects (executive function, attention and focus, inspiration, perceived stress, work engagement, and mindfulness) as well as self-reported sleep quality, immune health, productivity, and mood, researchers found that there was little difference between Qualia Mind and a placebo
placebo among participants whose body weight reduction had plateaued following GLP-1 therapy